Abstract
Effect of switching treatment to ranibizumab or aflibercept for diabetic macular edema in patients refractory to bevacizumab
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have